Bankers are lining up approximately €1 billion ($1.2 billion) in debt financing to back Apax Partners's purchase of two businesses from packaging firm Gerresheimer AG. The financing is expected to be in the form of leveraged loans, including term loans and a revolving credit facility, according to people familiar with the deal, who asked not to be identified because the matter is private. The debt is likely to be sold to institutional investors later this year.

A bank list is set to be confirmed shortly. The transaction involves units from Gerresheimer AG, a global player in the pharmaceutical packaging and injection delivery systems market. The deal highlights continued strong investor interest in the healthcare sector despite broader market volatility.